The Nomination Committee of Probi has been appointed

AP4 is represented by Jannis Kitsakis, Portfolio Manager.

The Nomination Committee of Probi has now been appointed in accordance with the AGM resolutions.

AP4 is represented by Jannis Kitsakis, Portfolio Manager.

The other members in the committee is:

  • Heniz-J├╝rgen Bertram, Symrise
  • Marianne Flink, Swedbank Robur Fonder
  • Bengt Jeppsson, Lund University

Probi is a Swedish publicly traded bioengineering company that develops effective and well-documented probiotics. Probi's products are available to consumers in more than 30 countries worldwide. In 2016 Probi had sales of 444 MSEK. The Probi share is listed on Nasdaq Stockholm.


Jannis Kitsakis

Jannis Kitsakis is Portfolio manager at AP4 and has now been appointed as member of Probi's Nomination Committee.